CRIPPA VALENTINA
Pubblicazioni
(2024). Characterizing Molecular Pathways and Therapeutic Prospects in MDS/MPN Neoplasms: A Focus on SETBP1 Mutations. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2024). Dettaglio
Crippa, V., Fontana, D., Civettini, I., Mologni, L., Piazza, R., Gambacorti Passerini, C., et al. (2024). Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer. Intervento presentato a: AACR Annual Meeting 2024 - April 5 - 10, 2024, San Diego, Ca, Usa. Dettaglio
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Dettaglio
Crippa, V., Fina, E., Ramazzotti, D., Piazza, R. (2024). Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data. BMC BIOINFORMATICS, 25(1) [10.1186/s12859-024-05694-w]. Dettaglio
Aroldi, A., Angaroni, F., D’Aliberti, D., Spinelli, S., Crespiatico, I., Crippa, V., et al. (2023). Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. VIRUSES, 15(1) [10.3390/v15010007]. Dettaglio